Hepatitis C Medications
Approved Medications
- FDA Drug Safety Communication: Important Drug Interactions Between Victrelis (Boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs (February 8, 2012)
From U.S. Food and Drug Administration
- Results of Pharmacokinetic Study in Healthy Volunteers Given Victrelis™ (Boceprevir) and Ritonavir-Boosted HIV Protease Inhibitors May Indicate Clinically Significant Drug Interactions for Patients Coinfected With Chronic Hepatitis C and HIV (February 6, 2012)
To read PDF, click here.
From Merck & Co., Inc.
- New Hepatitis C Treatment Available in Australia (February 2, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
 Top 10 HIV/AIDS-Related Clinical Developments of 2011 (December 1, 2011)
From The Body
- Telaprevir (Incivek, Incivo) (October 15, 2011)
To read PDF, click here.
From AIDS InfoNet
- Vertex, J&J Hepatitis C Drug Gets European Union Nod (September 22, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- FDA Supplemental Information About Using Boceprevir and Telaprevir (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- FDA Approve Telaprevir (Incivek) to Treat Hepatitis C (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- FDA Approve Boceprevir (Victrelis) for HCV (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Boceprevir (Victrelis) (July 31, 2011)
To read PDF, click here.
From AIDS InfoNet
- European Union Approves Merck's Hepatitis C Drug Victrelis (July 20, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
 Q&A on Hepatitis C and African Americans With Jonathan McCone, M.D., Victrelis Researcher (July 6, 2011)
From The Body
 Why Incivek and Victrelis Herald a New Era in Hepatitis C Treatment (June 2, 2011)
From The Body
- FDA Approves Incivek (Telaprevir) for Hepatitis C (May 23, 2011)
From U.S. Food and Drug Administration
- Merck's Hepatitis C Drug Wins FDA Approval (May 18, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Approval of Victrelis (Boceprevir), a Direct-Acting Antiviral Drug to Treat Hepatitis C Virus (May 15, 2011)
From U.S. Food and Drug Administration
- Both Hepatitis C Drugs Work About the Same: Study (August 11, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- An Overview of Peginterferon Alfa-2 (Pegasys, PEG-Intron) (March 16, 2007)
From AIDSinfo
- An Overview of Interferon Alfa-2 (Roferon-A, Intron A) (March 13, 2007)
From AIDSinfo
- An Overview of Ribavirin (Copegus, Rebetol, Virazole) (February 12, 2007)
From AIDSinfo
- ddI + Ribavirin May Cause Mitochondrial Toxicity (September 1, 2005)
In Journal of Acquired Immune Deficiency Syndromes
- New Hepatitis C Treatment Options Available (September 20, 2004)
Updates on generic ribavirin and the approval of two forms of peg-interferon.
To read PDF, click here.
From PositiveWords
- Focus on Hepatitis: Final APRICOT, ACTG A5071 Results (September 2004)
Data indicate that sustained virologic response can be achieved with peginterferon-alfa and ribavirin in many HIV/hepatitis C-coinfected patients.
To read PDF, click here.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Hepatitis C and Complementary and Alternative Medicine: 2003 Update (May 2004)
[Archived Article]
To read PDF, click here.
From U.S. National Center for Complementary and Alternative Medicine
- HCV Treatment and Monitoring Guide (August 2003)
[Archived Article]
A basic guide to hepatitis C medications.
To read PDF, click here.
In WISE Words, from Project Inform
- The Management of Adverse Effects with PEG-Interferon/Ribavirin Combination Therapy is a Significant Challenge (March 2003)
[Archived Article]
To read PDF, click here.
From HCV Advocate
- FDA Approves Pegasys for Hepatitis C (October 17, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Study: Hepatitis Shots Show Promise (September 26, 2002)
[Archived Article]
In a recent study, peginterferon alfa-2a plus ribavirin beats the standard hepatitis C treatment.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Why Interferon Induction Therapy Has Been a Failure (April 2002)
[Archived Article]
To read PDF, click here.
From HCV Advocate
- Important Drug Warning: Intron A (PDF) (December 2001)
[Archived Article]
From U.S. Food and Drug Administration
- Novel Treatments for HCV (October 21, 2001)
[Archived Article]
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from The Body PRO
- Hepatitis C: Progress Beyond Interferon (October 19, 2001)
[Archived Article]
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from The Body PRO
- FDA Approves Peg-Interferon and Ribavirin Treatment Combination (September 21, 2001)
[Archived Article]
To read PDF, click here.
In STEP Ezine, from Seattle Treatment Education Project
- Important Drug Warning: Roferon-A (PDF) (September 2001)
[Archived Article]
From U.S. Food and Drug Administration
- FDA Approves Stand-Alone Package of Rebetol (Ribavirin) for Combination Therapy With Intron A for the Treatment of Chronic Hepatitis C Infection (July 26, 2001)
[Archived Article]
See also Rebetol (Ribavirin) Product Information (2001) (PDF).
From U.S. Food and Drug Administration
- Revised Package Insert: Roferon-A (Interferon Alfa-2a, Recombinant) (PDF) (March 20, 2001)
[Archived Article]
From U.S. Food and Drug Administration
- Peg-Interferon-Alfa Approved for Hepatitis C (March 2001)
[Archived Article]
In What's New, from Project Inform
- Revised Package Insert: Intron A (Interferon Alfa-2b, Recombinant for Injection) (PDF) (February 2001)
[Archived Article]
From U.S. Food and Drug Administration
- New Drugs in Development: Pegylated Interferons for the Treatment of Hepatitis C (Summer 2000)
[Archived Article]
To read PDF, click here.
In CRIA Update, from AIDS Community Research Initiative of America
- Evolving Strategies to Attack Hepatitis C (December 1998)
[Archived Article]
New treatment combinations are highly toxic but have substantial success rates.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Hepatitis C: New Treatment Overview (September 4, 1998)
[Archived Article]
From AIDS Treatment News
- Can Science Meet the Challenges of the HCV Pandemic? (July 1998)
[Archived Article]
New treatment options for chronic Hepatitis C.
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care
- Ribavirin Approved for Hepatitis C Combination Treatment (June 22, 1998)
[Archived Article]
From AIDS Treatment News
- Hepatitis C -- Important Treatment Advance (May 15, 1998)
[Archived Article]
An interview with Douglas Dieterich, M.D.
In AIDS Treatment News, from AIDS Treatment News
- Hepatitis C and HIV: Ribavirin Plus Interferon Study Recruiting (May 15, 1998)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Alright Thymosin! (April 1996)
[Archived Article]
In Notes From the Underground, from PWA Health Group
Drug Pricing
|
Advertisement
|
Email
Glossary
